Becton, Dickinson and Co. | BDX - Assets

Stock Price
207.87
Daily Change
1.37 0.66%
Monthly
4.48%
Yearly
-15.18%
Q1 Forecast
197.21

Becton, Dickinson and Co. reported $55.32B in Assets for its fiscal quarter ending in September of 2025.





Assets Change Date
Abbott USD 84.18B 182M Sep/2025
Agilent USD 12.73B 501M Sep/2025
Align Technology USD 6.23B 14.46M Sep/2025
Avanos Medical USD 1.07B 28.7M Sep/2025
Baxter International USD 21.07B 21M Sep/2025
Becton, Dickinson and Co. USD 55.32B 423M Sep/2025
Bio-Rad Laboratories USD 9.7B 517.7M Sep/2025
Boston Scientific USD 42.71B 1.15B Sep/2025
Cooper Companies USD 12.39B 18.1M Sep/2025
Danaher USD 83.46B 3.57B Dec/2025
Dentsply International USD 5.65B 416M Sep/2025
Dexcom USD 7.5B 173M Sep/2025
Edwards Lifesciences USD 13.27B 216.5M Sep/2025
Exact Sciences USD 5.9B 102.64M Sep/2025
Globus Medical USD 5.1B 134.55M Sep/2025
Hologic USD 9.18B 165.8M Dec/2025
Insulet USD 3.03B 439.9M Sep/2025
Integra LifeSciences USD 3.65B 21.45M Sep/2025
Intuitive Surgical USD 20.46B 1.11B Dec/2025
J&J USD 192.82B 573M Sep/2025
Masimo USD 1.82B 585.1M Sep/2025
Medtronic USD 90.97B 708M Jun/2025
Solventum Corp USD 13.97B 1.1B Sep/2025
Stryker USD 47.84B 787M Dec/2025
Tandem Diabetes Care USD 874.65M 1.08M Sep/2025
Teleflex USD 7.87B 496.72M Sep/2025
Terumo JPY 1.89T 95.38B Sep/2025
Thermo Fisher Scientific USD 110.34B 7.32B Dec/2025
Zimmer Biomet Holdings USD 23.49B 622.9M Sep/2025